Related Experiment Video
Updated: Jun 29, 2026
04:59
Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
Published on: July 7, 2023
The COXIB experience: a look in the rearview mirror
1Department of Biochemistry, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA. larry.marnett@vanderbilt.edu
Annual Review of Pharmacology and Toxicology
|October 15, 2008
Summary
Cyclooxygenase-2 (COX-2) inhibitors, or COXIBs, offered reduced gastrointestinal risks but revealed significant cardiovascular risks. This review details COXIB development, lessons learned, and future directions for NSAID research.
Area of Science:
- Pharmacology
- Drug Development
- Molecular Biology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- Cyclooxygenase (COX) enzymes, particularly COX-2, were identified as key targets for NSAIDs.
- The hypothesis proposed that selective COX-2 inhibition would maintain anti-inflammatory benefits while reducing gastrointestinal side effects associated with COX-1 inhibition.
Observation:
- Early COX-2 selective inhibitors (COXIBs) demonstrated reduced gastrointestinal toxicity compared to traditional NSAIDs.
- COXIBs achieved significant commercial success due to their improved gastrointestinal safety profile.
- Clinical trials investigating COXIBs for colon polyp prevention unexpectedly revealed mechanism-based adverse cardiovascular effects.
Findings:
- The initial therapeutic promise of COXIBs was tempered by the discovery of serious cardiovascular risks.
- Understanding the differential roles of COX-1 and COX-2 has been crucial in evaluating NSAID liabilities.
- Adverse cardiovascular events associated with COXIBs are linked to their specific mechanism of action.
Implications:
- The development of COXIBs highlights the complexity of targeting specific enzyme isoforms.
- Further research is needed to balance the anti-inflammatory benefits of NSAIDs with their potential cardiovascular and gastrointestinal risks.
- Future drug development strategies may require a more nuanced approach to enzyme inhibition and patient stratification.
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
02:02Chair Conformation of Cyclohexane
The chair conformation is the most stable form of cyclohexane due to the absence of angle and torsional strain. The absence of angle strain is a result of cyclohexane’s bond angle being very close to the ideal tetrahedral bond angle of 109.5° in its chair conformer. Similarly, the torsional strain is also absent owing to the perfectly staggered arrangement of bonds.
The hydrogen atoms linked to carbons are arranged in two different axial and equatorial orientations to achieve this staggered...
The hydrogen atoms linked to carbons are arranged in two different axial and equatorial orientations to achieve this staggered...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:20Internal Combustion Engine
The internal combustion engine is a heat engine that uses the byproducts of combustion as the working fluid instead of using a heat transfer medium to transfer heat. The combustion is done in a way that produces high-pressure combustion products that can be expanded through a turbine or piston to create work. Internal combustion engines can again be categorized into three kinds: (1) spark ignition gasoline engines, most commonly used in automobiles, (2) compression ignition diesel engines that...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
02:28Cycloalkanes
Cycloalkanes are saturated cyclic hydrocarbons with carbon atoms arranged in the form of rings. They have two fewer hydrogen atoms than the corresponding acyclic alkane; therefore, their general formula is CnH2n. The structural formulas of cycloalkanes are simplified using the line-angle representation. The regular polygons are used to represent the cycloalkane rings, with each side representing a carbon-carbon bond.
The IUPAC nomenclature of cycloalkanes follows similar rules that apply to...
The IUPAC nomenclature of cycloalkanes follows similar rules that apply to...